- Common shares of Satellos Bioscience (MSCL) have commenced trading on the OTCQB Venture Market (OTCQB) under the symbol MSCLF
- Shares in Satellos will continue to trade on the TSXV under the symbol MSCL
- The OTCQB is the premiere marketplace for early-stage and developing companies that are committed to providing a high-quality trading and information experience for their U.S. investors
- Satellos Bioscience Inc. is a biotechnology company dedicated to developing life-changing medicines to treat degenerative muscle conditions
- Satellos Bioscience Inc. was unchanged at $0.325 at 10:28 AM ET
Common shares of Satellos Bioscience (MSCL) have commenced trading on the OTCQB Venture Market (OTCQB) under the symbol MSCLF.
Shares in Satellos will continue to trade on the TSXV under the symbol MSCL.
“Listing on the OTCQB is a testament to the foundational success we’ve experienced to date,” noted Satellos Co-Founder and CEO Frank Gleeson.
“The retail and institutional investment communities in the United States will now have easier access to playing a part in the advancements we’re making to improve the lives of individuals suffering from a wide range of muscular dystrophies,” he added.
The OTCQB is the premiere marketplace for early-stage and developing companies that are committed to providing a high-quality trading and information experience for their U.S. investors.
To qualify for OTCQB, companies must meet high financial standards, follow best-practice corporate governance, and demonstrate compliance with applicable securities laws. T
The OTCQB quality standards provide a strong baseline of transparency as well as the technology and regulation to improve the information and trading experience for investors.
The OTCQB is recognized by the Securities and Exchange Commission (SEC) as an established public market providing public information for the analysis and value of securities.
Satellos Bioscience Inc. is a biotechnology company dedicated to developing life-changing medicines to treat degenerative muscle conditions.
Satellos Bioscience Inc. was unchanged at $0.325 at 10:28 AM ET.
